InsiderSignal.AI

InsiderSignal.ai

EXEL - Exelixis, Inc.

Insider Sale by Wyszomierski Jack L (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Wyszomierski Jack L, serving as Dir at Exelixis, Inc. (EXEL), sold 99,574 shares at $44.01 per share, for a total transaction value of $4,382,252.00. Following this transaction, Wyszomierski Jack L now holds 279,942 shares of EXEL.

This sale represents a 26.00% decrease in Wyszomierski Jack L's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 20, 2026, 2 days after the trade was made.

Exelixis, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Wyszomierski Jack L

Dir

Jack L. Wyszomierski is an Independent Director at Exelixis, Inc. (EXEL) since 2004, currently serving as Chair of the Audit Committee and a member of the Nominating & Corporate Governance Committee.[[1]](https://fintool.com/app/research/companies/EXEL/people/jack-l-wyszomierski)[[5]](https://www.fidelity.co.uk/factsheet-data/factsheet/US30161Q1040USD-exelixis-inc/profile) Aged 69, he brings extensive expertise in financial reporting, accounting, and the healthcare sector, designated as an 'audit committee financial expert' by the board.[[1]](https://fintool.com/app/research/companies/EXEL/people/jack-l-wyszomierski) Wyszomierski held senior finance roles, including Executive Vice President and Chief Financial Officer at VWR International, LLC (2004–2009) and Schering-Plough Corporation (CFO from 1996 to 2003, with earlier positions from 1982).[[1]](https://fintool.com/app/research/companies/EXEL/people/jack-l-wyszomierski)[[3]](https://investors.xoma.com/corporate-governance/board-of-directors) He earned an M.S. in Industrial Administration and a B.S. in Administration, Management Science & Economics from Carnegie Mellon University.[[1]](https://fintool.com/app/research/companies/EXEL/people/jack-l-wyszomierski) Currently, he is Chairman of XOMA Royalty Corp. (since 2024) and a director at SiteOne Landscape Supply, Inc. (since 2016), with prior board roles at Athersys, Inc., Unigene Laboratories, and others; he owns approximately 356,605 shares of EXEL valued at over $16 million as of early 2025.[[1]](https://fintool.com/app/research/companies/EXEL/people/jack-l-wyszomierski)[[2]](https://www.gurufocus.com/insider/17696/jack-l-wyszomierski)[[3]](https://investors.xoma.com/corporate-governance/board-of-directors)

View full insider profile →

Trade Price

$44.01

Quantity

99,574

Total Value

$4,382,252.00

Shares Owned

279,942

Trade Date

Wednesday, February 18, 2026

3 days ago

SEC Filing Date

Friday, February 20, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Exelixis, Inc.

Company Overview

No company information available
View news mentioning EXEL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4158351

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime